Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05363111
Status:
RECRUITING
Last Update Posted:
2024-01-25
First Post:
2022-05-03
Brief Title:
Radioimmunotherapy 111Indium225Actinium-DOTA-daratumumab for the Treatment of RelapsedRefractory Multiple Myeloma
Sponsor:
Organization:
City of Hope Medical Center